Sarah has 10 years of experience in the medical device and combination product space, including 6 years at the FDA as a Product Jurisdiction Officer and Policy Analyst within CDRH, as well as several years as a Reviewer and Team Leader for injection devices. She brings expertise in regulatory strategy, with a particular focus on drug delivery devices and the unique challenges of combination products. While at the FDA, Sarah served as a key point of contact for external stakeholders, guiding industry sponsors through FDA expectations and complex regulatory issues. She also represented the Agency at national conferences, speaking on topics such as combination product regulation, policy development, and review considerations.